Call：+86 13413644741 
E-mail：market@ca-marketresearch.com Digital biomarkers are defined as objective, quantifiable physiological and behavioral data that are collected and measured by means of digital devices such as portables, wearables, implantables, or digestibles. The data collected are typically used to explain, influence, and/or predict health-related outcomes. Digital biomarkers also represent an opportunity to capture clinically meaningful, objective data.
This report aims to provide a comprehensive presentation of the global market for Digital Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digital Biomarker. This report contains market size and forecasts of Digital Biomarker in global, including the following market information:
Global Digital Biomarker Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Digital Biomarker market was valued at US$ 398.5 million in 2022 and is projected to reach US$ 23440 million by 2029, at a CAGR of 79.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Philips and Novartis are the top 2 companies in global digital biomarker market and account for over 15% of total market share. Geographically speaking, Europe holds about 45% of global market share, followed by North America with about 35% share. In terms of type, passive digital biomarker segment holds an important share of about 65%. In terms of application, clinical disease segment accounts for about 80% of the total share.
CA MARKET RESEARCH CO.,LTD (CAR) has surveyed the Digital Biomarker companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Digital Biomarker Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Digital Biomarker Market Segment Percentages, by Type, 2022 (%)
Passive Digital Biomarker
Active Digital Biomarker
Global Digital Biomarker Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Digital Biomarker Market Segment Percentages, by Application, 2022 (%)
Clinical Disease
Daily Health
Global Digital Biomarker Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Digital Biomarker Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Digital Biomarker revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Digital Biomarker revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Philips
Johnson & Johnson
Pfizer
GE Healthcare
Novartis
Apple
Sanofi
GlaxoSmithKline
Bayer
Merck
Abbott Laboratories
Asahi Kasei
Biogen
Koneksa Health
Roche
Huma Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Digital Biomarker, market overview.
Chapter 2: Global Digital Biomarker market size in revenue.
Chapter 3: Detailed analysis of Digital Biomarker company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Digital Biomarker in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Copyright © 2012-2021 版权所有
备案号粤ICP备2021079044号
